Breo® Ellipta® Institutional Pack Fluticasone Furoate / Vilanterol 100 mcg - 25 mcg Powder 14 Doses

Features

• Once-daily BREO 100/25 is a prescription medicine used long term to treat chronic obstructive pulmonary disease (COPD) for better breathing and fewer flare-ups
• Once-daily BREO is a prescription medicine for adults whose asthma is not well controlled on a long-term asthma control medicine, like an inhaled corticosteroid
• BREO is not used to relieve sudden breathing problems and won't replace a rescue inhaler
• BREO ELLIPTA is a combination of fluticasone furoate, an inhaled corticosteroid (ICS), and vilanterol, a long-acting beta2-adrenergic agonist (LABA)
• Inhaler containing 2 foil blister strips of powder formulation for oral inhalation
• One strip contains fluticasone furoate 100 mcg per blister and the other contains vilanterol 25 mcg per blister
• The inhaler is packaged within a moisture-protective foil tray with a desiccant and a peelable lid

More Information

• SDS